Literature DB >> 20878672

Simple targeted arterial rendering (STAR) technique: a novel and simple method to visualize the fetal cardiac outflow tracts.

L Yeo1, R Romero, C Jodicke, S K Kim, J M Gonzalez, G Oggè, W Lee, J P Kusanovic, E Vaisbuch, S Hassan.   

Abstract

OBJECTIVE: To describe a novel and simple technique—simple targeted arterial rendering (STAR)—to visualize the fetal cardiac outflow tracts from dataset volumes obtained with spatiotemporal image correlation (STIC) and applying a new display technology (OmniView).
METHODS: We developed a technique to image the outflow tracts by drawing three dissecting lines through the four-chamber view of the heart contained in a STIC volume dataset. Each line generated the following plane: (a) Line 1: ventricular septum en face with both great vessels (pulmonary artery anterior to the aorta); (b) Line 2: pulmonary artery with continuation into the longitudinal view of the ductal arch; and (c) Line 3: long-axis view of the aorta arising from the left ventricle. The pattern formed by all three lines intersecting approximately through the crux of the heart resembles a star. The technique was then tested in 50 normal fetal hearts at 15.3–40.4 weeks' gestation. To determine whether the technique could identify planes that departed from the normal images, we tested the technique in four cases with proven congenital heart defects (ventricular septal defect (VSD), transposition of great vessels, tetralogy of Fallot and pulmonary atresia with intact ventricular septum).
RESULTS: The STAR technique was able to generate the intended planes in all 50 normal cases. In the abnormal cases, the STAR technique allowed identification of the VSD, demonstrated great vessel anomalies and displayed views that deviated from what was expected from the examination of normal hearts.
CONCLUSIONS: This novel and simple technique can be used to visualize the outflow tracts and ventricular septum en face in normal fetal hearts. Inability to obtain expected views or the appearance of abnormal views in the generated planes should raise the index of suspicion for congenital heart disease involving the great vessels and/or the ventricular septum. The STAR technique may simplify examination of the fetal heart and could reduce operator dependency.

Entities:  

Mesh:

Year:  2011        PMID: 20878672      PMCID: PMC3037449          DOI: 10.1002/uog.8841

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  44 in total

1.  Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries.

Authors:  C A Luck
Journal:  BMJ       Date:  1992-06-06

2.  Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies.

Authors:  R Achiron; J Glaser; I Gelernter; J Hegesh; S Yagel
Journal:  BMJ       Date:  1992-03-14

3.  Outcome of prenatally detected cardiac malformations.

Authors:  J F Smythe; J A Copel; C S Kleinman
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

4.  Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects.

Authors:  B Bromley; J A Estroff; S P Sanders; R Parad; D Roberts; F D Frigoletto; B R Benacerraf
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

5.  Prenatal screening for congenital heart disease.

Authors:  L D Allan; D C Crawford; S K Chita; M J Tynan
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

6.  Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view.

Authors:  J A Copel; G Pilu; J Green; J C Hobbins; C S Kleinman
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

7.  Fetal echocardiography. VIII. Aortic root dilatation--a marker for tetralogy of Fallot.

Authors:  G R DeVore; B Siassi; L D Platt
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

8.  Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region.

Authors:  G K Sharland; L D Allan
Journal:  Br J Obstet Gynaecol       Date:  1992-03

9.  The 'spin' technique: a new method for examination of the fetal outflow tracts using three-dimensional ultrasound.

Authors:  G R DeVore; B Polanco; M S Sklansky; L D Platt
Journal:  Ultrasound Obstet Gynecol       Date:  2004-07       Impact factor: 7.299

10.  The prenatal diagnosis of congenital heart disease--a practical approach for the fetal sonographer.

Authors:  G R DeVore
Journal:  J Clin Ultrasound       Date:  1985-05       Impact factor: 0.910

View more
  5 in total

1.  Prospective evaluation of the fetal heart using Fetal Intelligent Navigation Echocardiography (FINE).

Authors:  M Garcia; L Yeo; R Romero; D Haggerty; I Giardina; S S Hassan; T Chaiworapongsa; E Hernandez-Andrade
Journal:  Ultrasound Obstet Gynecol       Date:  2016-03-10       Impact factor: 7.299

2.  A Prospective Study of the Use of Fetal Intelligent Navigation Echocardiography (FINE) to Obtain Standard Fetal Echocardiography Views.

Authors:  Paola Veronese; Gianna Bogana; Alessia Cerutti; Lami Yeo; Roberto Romero; Maria Teresa Gervasi
Journal:  Fetal Diagn Ther       Date:  2016-06-17       Impact factor: 2.587

Review 3.  Three- and four-dimensional ultrasound in fetal echocardiography: an up-to-date overview.

Authors:  B M E Adriaanse; J M G van Vugt; M C Haak
Journal:  J Perinatol       Date:  2016-03-10       Impact factor: 2.521

Review 4.  Prenatal Diagnosis of Dextrocardia with Complex Congenital Heart Disease Using Fetal Intelligent Navigation Echocardiography (FINE) and a Literature Review.

Authors:  Lami Yeo; Suchaya Luewan; Dor Markush; Navleen Gill; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2017-06-23       Impact factor: 2.587

5.  Fetal Intelligent Navigation Echocardiography (FINE) Detects 98% of Congenital Heart Disease.

Authors:  Lami Yeo; Suchaya Luewan; Roberto Romero
Journal:  J Ultrasound Med       Date:  2018-03-30       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.